全基因組定序市場－全球產業規模、佔有率、趨勢、機會和預測，按產品與服務、類型、工作流程、應用、最終用戶、地區和競爭細分，2020-2030 年

2024 年全球全基因組定序 (WGS) 市值為 20.5 億美元，預計到 2030 年將達到 40.9 億美元，預測期內複合年成長率為 12.15%。由於 WGS 能夠分析生物體的整個基因藍圖，因此它已成為基因組學、個人化醫療、診斷和研究領域的基礎工具。定序技術的不斷進步、吞吐量的提高以及成本的下降正在擴大 WGS 在醫療保健、農業和法醫等不同領域的應用。 WGS 在臨床診斷中的日益整合以及公共和私人對基因組學的投資不斷擴大，進一步推動了市場發展勢頭。儘管高成本、資料管理複雜性和法規遵循等挑戰依然存在，但人工智慧和機器學習的整合以及新應用的出現預計將加速市場的成長軌跡。

關鍵市場促進因素

遺傳性疾病盛行率不斷上升

主要市場挑戰

全基因組定序成本高昂

主要市場趨勢

人工智慧與機器學習在基因組數據分析中的融合

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全基因組定序市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依產品及服務（儀器、耗材、服務）
  • 按類型（大型全基因組定序、小型全基因組定序）
  • 依工作流程（預測序、定序、數據分析）
  • 依應用（人類全基因組定序、植物全基因組定序、動物全基因組定序、微生物全基因組定序）
  • 按最終用戶（學術和研究機構、醫院和診所、製藥和生物技術公司、其他）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第6章：北美全基因組定序市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲全基因組定序市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙

第8章：亞太全基因體定序市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美全基因組定序市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東和非洲全基因組定序市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 最新動態
• 產品發布
• 併購

第13章：全球全基因體定序市場：SWOT分析

第 14 章：競爭格局

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Oxford Nanopore Technologies plc.
• Pacific Biosciences of California, Inc.
• BGI
• QIAGEN
• Agilent Technologies, Inc.
• ProPhase Labs, Inc.
• Psomagen, Inc
• Azenta US Inc..

第 15 章：策略建議

第16章調查會社について,免責事項

The Global Whole Genome Sequencing (WGS) Market was valued at USD 2.05 billion in 2024 and is expected to reach USD 4.09 billion by 2030, growing at a CAGR of 12.15% during the forecast period. WGS has become a foundational tool across genomics, personalized medicine, diagnostics, and research, owing to its ability to analyze an organism's entire genetic blueprint. Continuous advancements in sequencing technology, increased throughput, and declining costs are expanding WGS adoption across diverse sectors including healthcare, agriculture, and forensics. The growing integration of WGS in clinical diagnostics and expanding public and private investments in genomics are further driving market momentum. While challenges such as high costs, data management complexity, and regulatory compliance remain, the integration of AI and machine learning, along with the emergence of new applications, is expected to accelerate the market's growth trajectory.

Key Market Drivers

Increasing Prevalence of Genetic Disorders

The rise in genetic disorders globally is a key factor propelling the adoption of whole genome sequencing. Genetic conditions affect approximately 2-5% of live births, with a considerable global impact on childhood morbidity and mortality. With up to 80 million individuals estimated to be living with rare genetic disorders worldwide, the need for comprehensive diagnostic tools is escalating. WGS enables precise identification of genetic mutations, offering superior accuracy compared to traditional diagnostic methods. In countries like India, where nearly one million infants are born annually with genetic disorders-many undiagnosed-the use of WGS allows clinicians to detect conditions early and implement targeted treatments. This ability to provide early diagnosis, personalized care, and improved clinical outcomes positions WGS as a critical solution amid rising genetic health concerns.

Key Market Challenges

High Cost of Whole Genome Sequencing

Although sequencing costs have significantly declined, the overall expense associated with WGS remains a substantial barrier to widespread adoption, especially in low- and middle-income regions. While sequencing a genome can now be achieved for under $1,000, ancillary costs such as data analysis, storage, and advanced computational infrastructure add to the financial burden. Institutions must also invest in trained personnel to interpret complex genomic data. These cost-related challenges can limit access to WGS in smaller hospitals and research facilities, despite its long-term benefits in enhancing healthcare outcomes. This financial barrier continues to restrict the market's accessibility and full-scale integration into routine clinical practices.

Key Market Trends

Integration of Artificial Intelligence and Machine Learning in Genomic Data Analysis

A transformative trend in the WGS market is the growing use of artificial intelligence (AI) and machine learning (ML) for genomic data interpretation. The immense volume of data generated by WGS requires advanced analytics to extract meaningful insights. AI and ML technologies can identify complex patterns, predict mutation effects, and enhance the precision of personalized treatment strategies. These tools are revolutionizing clinical decision-making, enabling faster and more accurate diagnoses, supporting drug discovery, and optimizing research workflows. As AI-driven solutions continue to evolve, they will play a crucial role in scaling the utility of WGS across both clinical and research applications, enhancing efficiency and expanding its real-world impact.

Key Market Players

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Oxford Nanopore Technologies plc.
• Pacific Biosciences of California, Inc.
• BGI
• QIAGEN
• Agilent Technologies, Inc.
• ProPhase Labs, Inc.
• Psomagen, Inc
• Azenta US Inc.

Report Scope:

In this report, the Global Whole Genome Sequencing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Whole Genome Sequencing Market, By Product & Service:

• Instruments
• Consumables
• Services

Whole Genome Sequencing Market, By Type:

• Large Whole Genome Sequencing
• Small Whole Genome Sequencing

Whole Genome Sequencing Market, By Workflow:

• Pre-sequencing
• Sequencing
• Data Analysis

Whole Genome Sequencing Market, By Application:

• Human Whole Genome Sequencing
• Plant Whole Genome Sequencing
• Animal Whole Genome Sequencing
• Microbial Whole Genome Sequencing

Whole Genome Sequencing Market, By End User:

• Academic & Research Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Others

Whole Genome Sequencing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Whole Genome Sequencing Market.

Available Customizations:

Global Whole Genome Sequencing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Whole Genome Sequencing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Service (Instruments, Consumables, Services)
  • 5.2.2. By Type (Large Whole Genome Sequencing, Small Whole Genome Sequencing)
  • 5.2.3. By Workflow (Pre-sequencing, Sequencing, Data Analysis)
  • 5.2.4. By Application (Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing, Microbial Whole Genome Sequencing)
  • 5.2.5. By End User (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Whole Genome Sequencing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Type
  • 6.2.3. By Workflow
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Whole Genome Sequencing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Workflow
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Whole Genome Sequencing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Workflow
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Whole Genome Sequencing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Workflow
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Whole Genome Sequencing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Type
  • 7.2.3. By Workflow
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Whole Genome Sequencing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Workflow
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. United Kingdom Whole Genome Sequencing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Workflow
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. Italy Whole Genome Sequencing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Workflow
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. France Whole Genome Sequencing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Workflow
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Whole Genome Sequencing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Workflow
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia-Pacific Whole Genome Sequencing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Type
  • 8.2.3. By Workflow
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Whole Genome Sequencing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Workflow
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Whole Genome Sequencing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Workflow
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Whole Genome Sequencing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Workflow
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Whole Genome Sequencing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Workflow
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Whole Genome Sequencing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Workflow
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. South America Whole Genome Sequencing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Type
  • 9.2.3. By Workflow
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Whole Genome Sequencing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Workflow
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. Argentina Whole Genome Sequencing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Workflow
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. Colombia Whole Genome Sequencing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Workflow
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. Middle East and Africa Whole Genome Sequencing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Type
  • 10.2.3. By Workflow
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Whole Genome Sequencing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Workflow
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Saudi Arabia Whole Genome Sequencing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Workflow
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. UAE Whole Genome Sequencing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Workflow
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Whole Genome Sequencing Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Illumina, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Thermo Fisher Scientific Inc.
• 14.3. Oxford Nanopore Technologies plc.
• 14.4. Pacific Biosciences of California, Inc.
• 14.5. BGI
• 14.6. QIAGEN
• 14.7. Agilent Technologies, Inc.
• 14.8. ProPhase Labs, Inc.
• 14.9. Psomagen, Inc
• 14.10.Azenta US Inc..

15. Strategic Recommendations

16. About Us & Disclaimer